The cost-effectiveness of male HPV vaccination in the United States

The cost-effectiveness of male HPV vaccination in the United States

Highlights ► We modeled the impact and cost-effectiveness of HPV vaccination of males in the United States. ► The cost-effectiveness of male vaccination depended on vaccine coverage of females. ► HPV vaccination of 12-year-old males might potentially be cost-effective. ► Increasing female vaccine co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2011-10, Vol.29 (46), p.8443-8450
Hauptverfasser: Chesson, Harrell W, Ekwueme, Donatus U, Saraiya, Mona, Dunne, Eileen F, Markowitz, Lauri E
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Adult
Age
Allergy and Immunology
Applied microbiology
Biological and medical sciences
Cancer
Cervical cancer
Child
cost effectiveness
Cost-Benefit Analysis
Cost-effectiveness analysis
Costs
Disease transmission models
Economics
Female
Females
Fundamental and applied biological sciences. Psychology
girls
Human papillomavirus
Humans
Incidence
Male
Males
Medical screening
Microbiology
Miscellaneous
Models, Statistical
Neoplasia
oropharyngeal cancer
Papilloma
Papillomaviridae
Papillomavirus Infections - economics
Papillomavirus Infections - epidemiology
Papillomavirus Infections - prevention & control
Papillomavirus Infections - transmission
Papillomavirus Vaccines - administration & dosage
Papillomavirus Vaccines - economics
Papillomavirus Vaccines - immunology
Penis
Quality of Life
quality-adjusted life year
United States - epidemiology
Vaccination
Vaccination - economics
Vaccination - methods
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Vagina
Virology
Warts
Young Adult
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights ► We modeled the impact and cost-effectiveness of HPV vaccination of males in the United States. ► The cost-effectiveness of male vaccination depended on vaccine coverage of females. ► HPV vaccination of 12-year-old males might potentially be cost-effective. ► Increasing female vaccine coverage could be more efficient than male vaccination.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2011.07.096